Relay Therapeutics Inc. (RLAY)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

4.71

0.64%

After-hours Dec 13, 2024, 04:15 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18
Revenue	25.55M	1.38M	3.03M	82.65M	-	-
Cost of Revenue	5.27M	4.13M	3.92M	3.55M	2.85M	2.15M
Gross Profit	20.28M	-2.75M	-896.00K	79.11M	-2.85M	-2.15M
Operating Income	-373.00M	-299.27M	-364.70M	-55.80M	-84.05M	-49.89M
Interest Income	31.05M	8.79M	830.00K	3.40M	8.80M	1.11M
Pretax Income	-341.97M	-290.51M	-363.87M	-52.41M	-75.31M	-48.78M
Net Income	-341.97M	-254.26M	-496.81M	-49.01M	-66.50M	-48.78M
Selling & General & Admin	74.95M	65.98M	57.39M	38.59M	13.74M	8.86M
Research & Development	330.02M	246.35M	172.65M	99.86M	70.31M	41.03M
Other Expenses	-	-20.00K	-4.00K	-16.00K	-58.00K	-9.00K
Operating Expenses	398.55M	312.33M	230.04M	138.45M	84.05M	49.89M
Interest Expense	-	-	-	-	-	-
Selling & Marketing Expenses	-	-	-	-	-	-
Cost & Expenses	398.55M	312.33M	230.04M	138.45M	84.05M	49.89M
Income Tax	-	-36.25M	132.94M	-3.40M	-8.80M	1.10M
Shares Outstanding (Basic)	122.58M	112.23M	95.14M	42.62M	4.28M	2.49M
Shares Outstanding (Diluted)	122.58M	112.23M	95.14M	42.62M	4.28M	2.49M
EPS (Basic)	-2.79	-2.27	-5.22	-1.15	-15.53	-19.63
EPS (Diluted)	-2.79	-2.27	-5.22	-1.15	-15.53	-19.63
EBITDA	-374.15M	-306.82M	-222.18M	-52.25M	-81.20M	-47.73M
Depreciation & Amortization	5.27M	4.13M	3.92M	3.55M	2.85M	2.15M